Bausch Health Cos., Inc. (BHC)
6.325
+0.02
(+0.40%)
USD |
NYSE |
Aug 28, 16:00
6.325
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Shareholders Equity (Quarterly) : -1.771B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.771B |
| March 31, 2026 | -2.059B |
| December 31, 2025 | -554.00M |
| September 30, 2025 | -565.00M |
| June 30, 2025 | -764.00M |
| March 31, 2025 | -1.183B |
| December 31, 2024 | -1.279B |
| September 30, 2024 | -1.174B |
| June 30, 2024 | -1.175B |
| March 31, 2024 | -1.115B |
| December 31, 2023 | -1.022B |
| September 30, 2023 | -1.18B |
| June 30, 2023 | -663.00M |
| March 31, 2023 | -800.00M |
| December 31, 2022 | -692.00M |
| September 30, 2022 | -525.00M |
| June 30, 2022 | -693.00M |
| March 31, 2022 | -216.00M |
| December 31, 2021 | -106.00M |
| September 30, 2021 | -204.00M |
| June 30, 2021 | -687.00M |
| March 31, 2021 | -197.00M |
| December 31, 2020 | 535.00M |
| September 30, 2020 | 587.00M |
| June 30, 2020 | 474.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 719.00M |
| December 31, 2019 | 1.063B |
| September 30, 2019 | 2.482B |
| June 30, 2019 | 2.601B |
| March 31, 2019 | 2.693B |
| December 31, 2018 | 2.733B |
| September 30, 2018 | 3.153B |
| June 30, 2018 | 3.467B |
| March 31, 2018 | 4.424B |
| December 31, 2017 | 5.849B |
| September 30, 2017 | 5.327B |
| June 30, 2017 | 3.931B |
| March 31, 2017 | 3.893B |
| December 31, 2016 | 3.152B |
| September 30, 2016 | 4.167B |
| June 30, 2016 | 5.296B |
| March 31, 2016 | 5.655B |
| December 31, 2015 | 5.911B |
| September 30, 2015 | 6.342B |
| June 30, 2015 | 6.435B |
| March 31, 2015 | 6.452B |
| December 31, 2014 | 5.279B |
| September 30, 2014 | 5.123B |
| June 30, 2014 | 5.258B |
| March 31, 2014 | 5.090B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 11.49M |
| Lexaria Bioscience Corp. | 4.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.79B |
| Total Liabilities (Quarterly) | 25.60B |
| Debt to Equity Ratio | -11.73 |
| Current Ratio | 1.435 |
| Net Debt Paydown Yield | 7.93% |